Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

12 Tuberculosis Tanweiping

2,469 views

Published on

Published in: Health & Medicine, Technology
  • Be the first to comment

12 Tuberculosis Tanweiping

  1. 1. Childhood Tuberculosis Mbbs.weebly.com
  2. 2. Definition <ul><li>Tuberculosis is caused by Mycobacterium tuberculosis , isolated by Robert Koch in 1882 , M.bovis(seldom) </li></ul><ul><li>mainly involves the lungs, but may spread to other organs </li></ul><ul><li>consumption </li></ul>
  3. 3. Epidemiology <ul><li>19th century, 25% deaths by TB </li></ul><ul><li>1940s, effective medicines </li></ul><ul><li>2 billion people—one third of the world's population—been exposed TB </li></ul><ul><li>Annually, 8 million become ill with tuberculosis, 2 million people die </li></ul><ul><li>The morbidity / mortality are high in developing countries </li></ul><ul><li>incidences rates 113 per 100,000 in China </li></ul>
  4. 4. Epidemiology <ul><li>Age:60% Infant - <5yr </li></ul><ul><li>Male:female-1:1 (adults male predominate) </li></ul><ul><li>TB adults exposure </li></ul><ul><li><2yr,HIV coinfection, immunocompromise, malnutrition </li></ul><ul><li>HIV/AIDS, </li></ul><ul><li>drug-resistant </li></ul>
  5. 5. Etiology <ul><li>Tubercle bacillus: </li></ul><ul><li>aerobic,non-Motile,non-spore-forming, high </li></ul><ul><li>lipid content </li></ul><ul><li>acid-fast, weak Gram(+) </li></ul><ul><li>grows slowly </li></ul><ul><li>Sensitive to heat/sunlight tolerate in humid or dry or cold. withstand weak disinfectants and survive in a dry state for weeks . </li></ul>
  6. 6. Dr. Robert Koch discovered the tuberculosis bacilli in 1882 He received the Nobel Prize in physiology or medicine in 1905 for this discovery
  7. 7. <ul><li>Tuberculosis is transmitted by airborne droplet nuclei(containing tubercle bacilli ) </li></ul><ul><li>prolonged, frequent, or intense contact </li></ul>
  8. 8. <ul><li>Many droplet nuclei are capable of floating in environment for several hours </li></ul><ul><li>Large particles may be inhaled by person </li></ul><ul><li>breathing the same air and impact on the </li></ul><ul><li>trachea or wall of the upper airway </li></ul>
  9. 9. The transmission is determined <ul><li>The probability of contact with active — not latent — TB </li></ul><ul><li>intimacy and duration of contact </li></ul><ul><li>effectiveness of ventilation </li></ul><ul><li>number s and virulence of the M. tuberculosis strain in infectious droplets </li></ul>
  10. 10. Pathogenesis <ul><li>tubercle bacillus </li></ul>Human immunity
  11. 11. Pathogenesis <ul><li>90% infected with Mycobacterium tuberculosis asymptomatic, latent TB infection 10% progress to TB disease </li></ul><ul><li>if untreated, the death rate for these active TB cases is more than 50% </li></ul>
  12. 12. Pathogenesis <ul><li>mycobacteria -> pulmonary alveoli -> replicate within macrophages -> picked up by dendritic cells -> transport to local LN -> spread through bloodstream to other tissues/organs -> secondary TB lesions </li></ul><ul><li>primary site of infection : upper part of the lower lobe, or lower part of the upper lobe of lung </li></ul><ul><li>secondary TB lesions: apex of the upper lobes , peripheral lymph nodes, kidneys, brain, and bone </li></ul>
  13. 13. Human Immunity /hypersensitivity after TB infection <ul><li>Specific immunity after infected or given BCG vaccine </li></ul><ul><li>Cell-mediate immunity develops within 4-8 weeks after infected with bacillus </li></ul><ul><li>Many immunologic cells: Macrophages, T/B lymphocytes, fibroblasts involved </li></ul>
  14. 14. Two types of cells are essential in the formation of TB <ul><li>Macrophages: directly phagocytize TB and processing and presenting antigens to T lymphocyte </li></ul><ul><li>T lymphocytes(CD4+): induce protection through the production of lymphokines </li></ul>
  15. 15. T lymphocytes(CD4+) <ul><li>Many lymphokines are involved in tuberculosis, the interplay of these cytokines determine the hosts response for example </li></ul><ul><li>IL-1 is related to fever </li></ul><ul><li>IL-6 is related to hyperglobulinemia </li></ul><ul><li>TNF is related to the killing of mycobacteria formation of granulomas </li></ul><ul><li>other cytokines including IL-4,IL-5,IL-10 can promote humoral immunity </li></ul>
  16. 16. <ul><li>Genetic factors ( HLA-BW35) play a key role in innate non-immune resistance to infection with M. Tuberculosis </li></ul><ul><li>These genes may have a role in determining susceptibility to tuberculosis </li></ul>
  17. 17. Basic pathologic changes <ul><li>infiltration -> hyperplasia( granuloma) , ulceration or calcification in different stage </li></ul><ul><li>host defense < bacterias, caseating ulceration(caseous necrosis ) -> fibrosis </li></ul><ul><li>host defense > bacteria, granuloma calcification </li></ul>
  18. 18. A characteristic tubercle at low magnification ( A ) and in detail ( B ) central caseation surrounded by epithelioid and multinucleated giant cells(C) mycobacteria with acid-fast stains ( D ).
  19. 19. Progression of tuberculosis <ul><li>Absorption </li></ul><ul><li>Fibrosis </li></ul><ul><li>Calcification </li></ul><ul><li>Deterioration: enlargement of infected aeras and appear newer infiltrated regions or spreading. </li></ul>
  20. 20. Five common clinical patterns <ul><li>1. Primary pulmonary tuberculosis (Primary Complex and </li></ul><ul><li>Bronchial Lymphnode-Tuberculosis) </li></ul><ul><li>2. Milliary Tuberculosis (acute, subacute and chronic hematogenous pulmonary tuberculosis) </li></ul><ul><li>3. secondary pulmonary tuberculosis </li></ul><ul><li>Infiltrative pulmonary tuberculosis </li></ul><ul><li>Chronic fibrocavenous pulmonary tuberculosis </li></ul><ul><li>4.Tuberculous pleuritis </li></ul><ul><li>5.Extrapulmonary tuberculosis </li></ul>
  21. 21. Diagnosis <ul><li>History and Clinical Manifestations </li></ul><ul><li>Tuberculin testing </li></ul><ul><li>Lab examination </li></ul><ul><li>X-r ay </li></ul><ul><li>bronchoscopy </li></ul><ul><li>Puncture of adenopathy </li></ul>
  22. 22. History /Clinical Manifestations <ul><li>systemic signs : fever, weight loss, fatigue, night sweats, wasting </li></ul><ul><li>TB Contaction : adults in family </li></ul><ul><li>History of BCG Vaccination </li></ul><ul><li>Acute infectious disease recently : measles,whooping cough </li></ul><ul><li>Allergy to TB : erythema nodosum 、 herpetic conjunctivitis </li></ul>
  23. 23. Tuberculin skin test <ul><li>a skin test to determine past or present infection with the tuberculosis bacterium; based on hypersensitivity of the skin to tuberculin </li></ul><ul><li>Method of test protein purified derivative PPD 0.1ml intradermal injection </li></ul><ul><li>Site : internal side of medium-distal 1/3 left forearm </li></ul><ul><li>6 - 10mm </li></ul><ul><li>Result : 48-72hrs, transverse </li></ul><ul><li>diameter </li></ul>
  24. 24. Result is read by measuring the diameter of induration 48-72hrs <ul><li>Induration <5mm negative </li></ul><ul><li>Induration 5-9mm(+) </li></ul><ul><li>Induration 10-19mm(++) </li></ul><ul><li>Induration 》 20mm (+++) </li></ul><ul><li>A positive tuberculin skin test indicates </li></ul><ul><li>tuberculous infection, with or without disease </li></ul>
  25. 25. <ul><li>Tuberculin testing </li></ul><ul><li>A positive tuberculin test is of great use in children, with limited diagnostic significance in adults </li></ul>
  26. 26. Clinical Significance <ul><li>Positive </li></ul><ul><li>Negative </li></ul>
  27. 27. Positive Reaction : indicates TB exposure <ul><li>BCG Vaccination </li></ul><ul><li>Children and adolescents(++) exposed to TB </li></ul><ul><li>Infant﹤3yrs (++) recent infection </li></ul><ul><li>(+++) Active TB infectin </li></ul><ul><li>(-) -> (+) , or Induration<10mm ->>10mm, ↑>6mm recent infection </li></ul>
  28. 28. Negative Reaction <ul><li>Never exposed to TB </li></ul><ul><li>Within 4-8wks of primary infectin </li></ul><ul><li>False negative:compromised immunity </li></ul><ul><li>Technique failure or PPD invalidated </li></ul>
  29. 29. PPD reaction of natural TB infection and BCG vaccination <ul><li>Natural infection </li></ul><ul><li>stronge </li></ul><ul><li>Induration >10-15mm </li></ul><ul><li>deep red 、 regular margin 、 hard </li></ul><ul><li>pigmentation </li></ul><ul><li>Long duration > 7-10d </li></ul><ul><li>Less change </li></ul><ul><li>BCG vaccination </li></ul><ul><li>weak </li></ul><ul><li>Induration 5-9mm </li></ul><ul><li>light red 、 unregular margin 、 soft </li></ul><ul><li>Short duration:2-3d </li></ul><ul><li>Become weak gradually,disappear3-5y </li></ul>
  30. 30. Laboratory examinations <ul><li>Sputum examination acid-fast staining </li></ul><ul><li>PCR test to detect TB DNA </li></ul><ul><li>TB antibody testing </li></ul><ul><li>ESR </li></ul><ul><li>Blood Routine </li></ul>
  31. 31. Chest radiography <ul><li>Chest X-ray: most important method to detect TB </li></ul><ul><li>Characteristics ,area, degree of activity or progress </li></ul><ul><li>Differentiation with other disease </li></ul><ul><li>Follow the effectivity of therapy </li></ul>
  32. 32. bronchoscopy <ul><li>Endobrochial tuberculosis </li></ul><ul><li>tuberculous tracheobronchial lymphadenitis </li></ul>
  33. 33. Puncture of peripherial LN <ul><li>Tubercle </li></ul><ul><li>caseous necrosis </li></ul>
  34. 34. Treatment <ul><li>Common therapy : </li></ul><ul><li>Nutrition 、 Rest </li></ul><ul><li>Ventilation </li></ul><ul><li>Isolation </li></ul>
  35. 35. Chemotherapy <ul><li>goal : Kill TB </li></ul><ul><li>Limit TB from spreading </li></ul><ul><li>principles : </li></ul><ul><li>earlier, appropriate </li></ul><ul><li>Combination, Full course </li></ul><ul><li>regularly and Staged . </li></ul>
  36. 36. Classification of antitubercular drug <ul><li>bactericidal </li></ul><ul><li>( 1 ) complete bactericidal : </li></ul><ul><li>INH 、 RFP </li></ul><ul><li>( 2 ) semi- bactericidal : </li></ul><ul><li>SM : alkaline, fast propagation, </li></ul><ul><li>intracellular TB </li></ul><ul><li>PZA : Acidic 、 slow growth </li></ul><ul><li>intracellular TB </li></ul>
  37. 37. <ul><li>medicines are classified as first-line and second-line agents </li></ul><ul><li>First-line essential antituberculous agents are the most effective and are necessary components of </li></ul><ul><li>any short-course therapeutic regimen </li></ul>
  38. 38. <ul><li>First-line medicines include </li></ul><ul><li>Isoniazid, rifampin, </li></ul><ul><li>pyraziniamide,streptomycine </li></ul><ul><li>Second-line medicines include </li></ul><ul><li>ethambutal, para-amino-salicylic acid, </li></ul><ul><li>kanamycin, amikacin and ects. </li></ul><ul><li>Newer antituberculous drugs </li></ul><ul><li>rifapentine, rifabutin quinolones </li></ul>
  39. 39. Isoniazid (INH) first-line drug <ul><li>Isoniazid is a principal agent used to treat TB </li></ul><ul><li>It is universally accepted for initial treatment </li></ul><ul><li>Now considered the best anti-TB drug </li></ul><ul><li>It should be included in all TB treatment regmens unless the organism is resistant </li></ul>
  40. 40. Advantages <ul><li>Inexpensive </li></ul><ul><li>Readily synthesized </li></ul><ul><li>Availabe worldwide </li></ul><ul><li>Highly selective for mycobacteria </li></ul><ul><li>Well tolerated(about only 5% of patients exhibiting adverse effects ) </li></ul>
  41. 41. Dosage <ul><li>Tuberculosis organization have recommended </li></ul><ul><li>5 mg/kg daily for both groups </li></ul><ul><li>Generally, 300mg daily oral dose is adopted </li></ul>
  42. 42. Adverse effects <ul><li>The two most important adverse effects of isoniazid therapy are hepatotoxicity </li></ul><ul><li>periphral neuropathy </li></ul><ul><li>We must measure liver enzymes before </li></ul><ul><li>administrating and during treatment </li></ul><ul><li>periods(usually monthly measure) </li></ul><ul><li>If the liver enzymes level is higher than </li></ul><ul><li>normal,the drug must be discontinued </li></ul>
  43. 43. Rifampin (RFP) first-line drug <ul><li>It is also considered the most important and potent antituberculous agent </li></ul><ul><li>Like isoniazid it is bactericidal and highly effective </li></ul><ul><li>Unlike isoniazid, it is also effective against most other mycobacteria as well as other organisms </li></ul>
  44. 44. Chemotherapy Regimens <ul><li>Standard regimen : </li></ul><ul><li>asymptomatic primary infection </li></ul><ul><li>INH 、 RFP and/ ( or ) EMB </li></ul><ul><li>9-12 months </li></ul>
  45. 45. Two Stage Therapy <ul><li>Active primary TB 、 Disseminated TB 、 TB meningitis </li></ul><ul><li>Enforcement stage : 3-4 bactericidal , 3-4m </li></ul><ul><li>Consolidation stage : 2 drug , 12-18m </li></ul>
  46. 46. Short-term Therapy <ul><li>2 or 3 drugs killing of organisms + 1 </li></ul><ul><li>drug restraint of organisms </li></ul><ul><li>Mild/moderate with small infiltrates and thin wall cavities : </li></ul><ul><li>INH+RFP+SM(EMB) (PZA) 2 M or </li></ul><ul><li>INH+RFP 4 -7 M </li></ul><ul><li>extensive /severe, large areas of caseation or thick-walled cavities are identified: </li></ul><ul><li>INH+RFP+SM+EMB(PZA) 2 M or </li></ul><ul><li>INH+RFP 4 -7 M </li></ul>
  47. 47. Prevention <ul><li>Prevention of Tuberculosis : Vaccination </li></ul><ul><li>BCG Vaccination can obtain immunity acquired for tubercle bacillus. one of the most important tuberculosis prevention </li></ul><ul><li>Vaccination target: infants children and youngster of tuberculin negative (vaccination is of course of no use in tuberculin-positive persons) </li></ul>
  48. 48. Prevention <ul><li>Finding patients earlier </li></ul><ul><li>Treatment and management of patients </li></ul><ul><li>Prevention with medicines </li></ul><ul><li>The systemic organization of prevention </li></ul>
  49. 49. Prophylatic chemotherapy <ul><li>Intimate contact with family members suffering active TB </li></ul><ul><li><3y infant PPD test(++) without BCG viccination </li></ul><ul><li>PPD test (-) -> (+) recently </li></ul><ul><li>PPD test(++) accompanied by Tb toxic symptoms </li></ul><ul><li>PPD test(++) , suffered measles,whooping cough </li></ul><ul><li>PPD test(++) and need long term steroid therapy </li></ul>
  50. 50. <ul><li>Regimen: </li></ul><ul><li>INH : 10mg/kg.d , 6-9m </li></ul>
  51. 51. Tuberculous meningitis
  52. 52. Pathogenesis <ul><li>Spreading through bloodstream </li></ul><ul><li>Rupture of TB lesion->bacteria enter choroids plexuses -> CSF </li></ul><ul><li>Extension from nearby organ infected with TB </li></ul>
  53. 53. Clinical Manifestation <ul><li>The 1st Stage: 1-2wks </li></ul><ul><li>change of character:irritability, </li></ul><ul><li>Tb toxic symptom </li></ul><ul><li>Headaches ( vomiting 、 </li></ul><ul><li>drowsiness ) </li></ul>
  54. 54. The 2nd Stage 1-2wks <ul><li>Meningeal irritation stage </li></ul><ul><li>Increased ICP: Headaches,vomiting, drowsiness, seizure, nuchal rigidity, back pain, Kerning sign, Brudzinski sign. </li></ul><ul><li>Cranial Nerve palsy </li></ul><ul><li>Encephalitis:disorentation,movement disorders, speech impaiment, papilledema </li></ul>
  55. 55. The 3rd Stage <ul><li>Coma stage 1-3wks </li></ul><ul><li>coma, hemiplegia, paraplegia, convulsion consumption, abnormal metabolise of electrolyte </li></ul><ul><li>hypertenion, decerebrate posture </li></ul><ul><li>brain hernia->death </li></ul>
  56. 56. Diagnosis <ul><li>Medical history </li></ul><ul><li>Clinical manifestation </li></ul><ul><li>CSF examination </li></ul><ul><li>X -ray check </li></ul><ul><li>CT or MRI scanning </li></ul><ul><li>Tuberculin test </li></ul>
  57. 57. Differentiation diagnosis <ul><li>Meningococcal Meningitis </li></ul><ul><li>Viral Meningitis </li></ul><ul><li>cryptococcal meningitis </li></ul><ul><li>Cerebral tumor </li></ul>
  58. 58. Treatment <ul><li>General therapy </li></ul><ul><li>Anti-tuberculous therapy </li></ul><ul><li>Decreasing intracranial pressure </li></ul><ul><li>corticosteroids </li></ul><ul><li>Anti-symptomatic therapy </li></ul><ul><li>Follow -up </li></ul>
  59. 59. Anti-tuberculous therapy <ul><li>1、 The initial stage : </li></ul><ul><li>  3-4 m </li></ul><ul><li>  INH、RFP、PZA、SM </li></ul><ul><li>2、 The 2nd stage </li></ul><ul><li>  INH、RFP </li></ul><ul><li>  12 m </li></ul>
  60. 60. Latent infection of tuberculosis <ul><li>A patient is infected with Mycobacterium tuberculosis , but does not have active disease </li></ul><ul><li>Patients with latent tuberculosis are not infectious </li></ul><ul><li>The main risk is that approximately 10% of these patients will go on to develop active tuberculosis at a later stage of their life </li></ul><ul><li>The identification and treatment of people with latent TB is an important part of controlling this disease. </li></ul>
  61. 61. Miliary tuberculosis in an infant whose uncle also had tuberculosis. There is adenopathy in addition to the millet seed–like lesions
  62. 63. A posteroanterior (A) and lateral (B) chest radiograph of a child with hilar adenopathy caused by Mycobacterium tuberculosis.
  63. 64. Hilar and mediastinal adenopathy and a partial segmental lesion in a child with tuberculosis
  64. 65. Lobar pneumonia with bowing of the horizontal fissure in a child with tuberculosis. a secondary bacterial pneumonia may have been present
  65. 66. Tuberculous pleural effusion in a teenage girl. The pleural biopsy had caseating granulomas
  66. 67. A magnetic resonance image of tuberculoma in a child with culture-positive tuberculous meningitis. The child's presenting signs and symptoms included fever, altered mental status, and hemiparesis
  67. 68. Thank you

×